BlackRock Fund Advisors - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 111 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2016. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2016$25,864,000
-38.4%
842,478
+34.6%
0.01%
-44.4%
Q3 2016$41,975,000
+134.0%
626,024
+4.0%
0.01%
+125.0%
Q2 2016$17,936,000
+164.5%
602,071
+160.7%
0.00%
+100.0%
Q1 2016$6,782,000
-64.3%
230,920
-4.7%
0.00%
-50.0%
Q4 2015$19,006,000
+10.9%
242,424
+6.6%
0.00%0.0%
Q3 2015$17,133,000
-35.9%
227,353
-0.7%
0.00%
-33.3%
Q2 2015$26,741,000
-82.6%
229,042
-64.8%
0.01%
-83.8%
Q1 2015$153,457,000
+34.4%
649,940
+7.8%
0.04%
+32.1%
Q4 2014$114,145,000
-10.8%
603,082
+12.4%
0.03%
-22.2%
Q3 2014$127,994,000
+266.4%
536,506
+1.4%
0.04%
+260.0%
Q2 2014$34,935,000
-42.3%
529,311
-9.0%
0.01%
-44.4%
Q1 2014$60,582,000
+7.6%
581,739
+7.0%
0.02%
+5.9%
Q4 2013$56,278,000
+84.0%
543,593
-4.7%
0.02%
+70.0%
Q3 2013$30,593,000
+36.8%
570,135
+13.1%
0.01%
+25.0%
Q2 2013$22,367,000504,0980.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2016
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders